All of them are radiotracers that bind with high affinity to the extracellular domain of PSMA and have demonstrated efficacy in detecting PC at various stages of the disease, with increased uptake correlating with tumor aggressiveness [21,22]. Here, FOLH1 is linked to pachyonychia congenita.